A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion

计划入组 202 人 · 首次发布于 2011 年 1 月 14 日

Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion

计划入组 150 人 · 首次发布于 2011 年 9 月 5 日

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

计划入组 46 人 · 首次发布于 2014 年 11 月 27 日

Retinal vein occlusion(RevOpsis)

Diabetic macular edema(RevOpsis)

Uveitic macular edema(RevOpsis)

RETINAL CONSULTANTS

United States

Optiva Inc

Australia

RETINAL CARE INC.

United States

Eylea HD Shows Promise in Macular Edema Following Retinal Vein Occlusion

EMA Panel Recommends Aflibercept Biosimilar Eydenzelt for Retinal Disorders

FDA Approves Pavblu, Fifth Biosimilar to Eylea, for Retinal Conditions